In both T98G and U87 co-cultured with HSPCs, we also observed an increase in cell-surface expression of PD-L1 (Fig. 5c), indicating that HSPCs may contribute to the immunosuppressive environment in glioblastoma progression by inducing the expression of immune checkpoint molecules on glioma cells. The gene discussed is CD274; the disease is central nervous system cancer.